loader2
Login Open ICICI 3-in-1 Account

Rallis India Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Rallis India Ltd. 16 Oct 2025 18:08 PM

Q2FY26 Quarterly Result Announced for Rallis India Ltd.

Agrochemicals company Rallis India announced Q2FY26 results

  • Company recorded revenue of Rs 861 crore, compared to Rs 928 crore in Q2FY25, reflecting a 7% decline.
  • PAT grew by 4% to Rs 102 crore, compared to Rs 98 crore in Q2FY25.
  • PAT margin improved by 120 basis points to 11.8%.
  • EBITDA for the quarter stood at Rs 154 crore as against Rs 166 crore in Q2FY25.
  • Free Cash Flow of Rs 52 crore, zero external debt, and a healthy closing cash and liquid balance of Rs 454 crore.

Gyanendra Shukla, Managing Director & CEO, Rallis India, said: Despite challenging weather conditions, the company delivered steady profitability and strong cash generation, supported by cost optimization, disciplined operations and robust export growth.

During the quarter, the company recorded revenue of Rs 861 crore, compared to Rs 928 crore in Q2FY25, reflecting a 7% decline mainly due to erratic and prolonged rains in several parts of the country that impacted field activities and spray applications. PAT grew by 4% to Rs 102 crore, compared to Rs 98 crore in Q2FY25. The company’s PAT margin improved by 120 basis points to 11.8%. EBITDA for the quarter stood at Rs 154 crore as against Rs 166 crore in Q2FY25. Strong cash management continued with Free Cash Flow of Rs 52 crore, zero external debt, and a healthy closing cash and liquid balance of Rs 454 crore.

For the half year ended September 2025, Rallis reported revenue of Rs 1,818 crore, a 6% increase over Rs 1,711 crore in H1FY25. EBITDA grew by 16% to Rs 303 crore compared to Rs 261 crore last year, while PAT grew 35% to Rs 197 crore against Rs 146 crore in H1FY25. The company achieved a PAT margin of 10.8%, up from 8.5% in the previous year, reflecting improved operational efficiency and a richer product mix.

Q2 was challenging due to prolonged rains which impacted field activities and product placement. Despite these headwinds, our profitability remained stable, supported by export momentum, prudent cost management, and improved margins in the Seeds business.

Our strong balance sheet, zero external debt and healthy cash position underscore our financial discipline and operational resilience.

Result PDF

Agrochemicals company Rallis India announced Q1FY26 results

  • Revenue: The company reported Rs 957 crore, a YoY increase of 22% over Rs 783 crore in Q1FY25.
  • Profit After Tax (PAT): PAT doubled to Rs 95 crore, up 100% from Rs 48 crore in Q1FY25.
  • PAT Margin: Net margin expanded from 6% to 10%, reflecting a richer product mix and cost optimisation.

Gyanendra Shukla, Managing Director & CEO, Rallis India, said: “Market placement during the first quarter of the year benefited from an early onset of monsoon. Global demand has also started showing signs of recovery in a few of our products.

Our revenue for Q1FY26 was at Rs 957 crore, 22% higher than Rs 783 crore of Q1FY25. Profit After Tax (PAT) was 95 crore in Q1FY26 as compared to Rs 48 crore in Q1FY25. We witnessed double-digit volume-led growth of 13% in Crop Care B2C, 23% in Crop Care B2B and 38% in Seeds business. Our Soil & Plant Health business registered growth of 33% in line with our strategy. Our actions on improving product mix and driving cost optimization have also helped in improving PAT margins from 6% in Q1FY25 to 10% in Q1FY26. We are pleased with the continuing momentum on our North Cotton seeds hybrids, particularly ‘Diggaz’. Our working capital management has also been robust, leading to a healthy closing fund balance.

We remain cautiously optimistic for the quarter ahead. Key watchouts will be the liquidation of placed products in both Crop Care B2C and Seeds. We expect the export market to witness a gradual recovery during the year.

On a long-term basis, Customer Centricity will remain a key thrust, and we will continue to offer differentiated solutions to solve varying farmer needs. We will further intensify our efforts to build capabilities in Manufacturing, Digitalization and leverage Collaborations and Alliances.”

Result PDF

Agrochemicals company Rallis India announced Q4FY25 & FY25 results

Q4FY25 Financial Highlights:

  • Revenue: Rs 430 crore compared to Rs 436 crore during Q4FY24,
  • PAT: Rs -32 crore compared to Rs -21 crore during Q4FY24.

FY25 Financial Highlights:

  • The company has reported FY25 revenue of Rs 2,663 crore, compared to Rs 2,648 crore during FY24.
  • PAT: Rs 125 crore compared to Rs 148 crore during FY24.

Gyanendra Shukla, Managing Director & CEO, Rallis India, said: The company has reported FY25 revenue of Rs 2663 crore and PAT of Rs 125 crore. For Q4FY25, revenue is Rs 430 crore with positive volume growth in domestic business. Control over Working capital has enabled strong Cash flow from Operations. I am particularly pleased with the growth of 23% and 24% in Soil & Plant Health and Herbicides categories respectively. Our Innovation Turnover Index is in line with our long-term target of 14%. Seeds business had a turnaround with FY25 PBT of Rs 18 crore primarily driven by North Cotton Hybrid “Diggaz” and cost optimization actions.

We will prioritize improving market share in the domestic business. In Exports and CSM Business, our focus is to expand product offerings and build strategic partnerships. We are strengthening our people’s capabilities by simplifying organization structure and inducting fresh talent.

Our long-term focus continues to be to offer differentiated product offerings which address farmers’ evolving needs. Continued investments in customer centricity, marketing, manufacturing, and digital capabilities will remain the key to delivering sustainable growth.

Result PDF

Agrochemicals company Rallis India announced 9MFY25 & Q3FY25 results

Q3FY25 Financial Highlights:

  • Q3 Revenue is down by 13% vs Q3 PY.
  • Crop Care revenue down by 13% vs Q3FY24. Seeds revenue down by 7% vs Q3FY24.
  • EBITDA down by 27% vs Q3FY24. Volume drop and pricing pressure in exports impacted margins.
  • PAT down by 56% vs Q3FY24 due to lower EBITDA.

9MFY25 Financial Highlights:

  • Revenue: Rs 2,233 crore compared to Rs 2,212 crore during 9MFY24.
  • EBITDA: Rs 306 crore compared to Rs 304 crore during 9MFY24.
  • PAT: Rs 157 crore compared to Rs 169 crore during 9MFY24.
  • Flat revenue in 9M due to weak export demand.

Result PDF

Agrochemicals company Rallis India announced Q2FY25 results

Financial Highlights:

  • Rallis India reported 11% YoY revenue growth of Rs 928 crore.
  • The company's profit after tax (PAT) stood at Rs 98 crore, marking a 21% increase compared to the previous year.

Gyanendra Shukla, Managing Director & CEO, Rallis India, said: “Strong domestic demand with above normal monsoon and better commodity prices. Volume recovery in international market although pricing continues to be muted”.

We had a strong Q2FY25 performance helped by double digit growth in the domestic market, both in the Crop Care and Seeds business. Revenue increased by 11% to reach Rs 928 crore and Profit after Tax increased by 21% to reach Rs 98 crore. Domestic Crop Care delivered volume led revenue growth of 11% with prices impacting overall realization. Seeds revenue was up by 48% due to better Kharif liquidation. International business had volume recovery though prices continue to be a challenge.

Our efforts will continue to be directed towards improving market share in domestic business. We remain positive for the upcoming Rabi season with higher reservoir water levels. Hybrid Seeds Production acres and cost continues to be a concern. Customer and product base expansion will remain a focus for international business.

On a long-term basis, Customer Centricity will be a key thrust, and we will continue to offer differentiated solutions to solve varying farmer needs. We will further intensify our efforts to build capabilities in Digital and leverage Collaborations and Alliances”.

Result PDF

Agrochemicals company Rallis India announced Q1FY25 results:

Business Highlights:

  • Successful Key New Products launches:
    • Crop Protection:
      • Mark Plus (Diclosulam 0.9% Pendimethalin 35% SE), 9(3) Herbicide for Soybean and Groundnut
      • Clifton (Mesotrione 2.27% Atrazine 22.7% SC), Herbicide for Maize and Sugarcane
      • Kevat (Pyrithiobac Sodium 10 % EC), Herbicide for Cotton
      • Blend (Bifenthrin 10% Thiamethoxam 5% SE), Insecticide for multiple crops
    • Crop Nutrition: Aquafert Pomegranate Grade Water Soluble Fertiliser
    • Seeds: 14 products across field and vegetable crops
  • “Dhaan ka power play" campaign launched to educate farmers of Punjab and Haryana about key Paddy products.

Announcing the results, Gyanendra Shukla, Managing Director & CEO, Rallis India, said, “The agrochemical Industry continues to face growth challenges due to muted price arising from oversupplies. Domestic demand is looking positive with monsoon arrival and pickup.

Our revenue for Q1FY25 was at Rs 783 crore at par with Rs 782 crore of Q1FY24, Profit after tax was Rs 48 crore, as compared to Rs 63 crore of Q1FY24. Crop care delivered strong volume led revenue growth of 8%. Seeds revenue was down by 16% vs PY largely due to supply constraints. Despite market challenges, concerted actions were taken to drive margins through better product mix and dynamic pricing. We are pleased with the progress of our new launch of “Clasto” in Crop Protection and “Diggaz” in Cotton Seeds. Water Soluble Fertilizers (WSF) plant was commissioned during the quarter to support the Crop Nutrition Business.

We remain cautious about the export market and expect a gradual recovery during the year. Sentiments for the domestic market are positive with the recent monsoon pick-up.

On a long-term basis, Customer Centricity will remain a key thrust and we will continue to offer differentiated solutions to solve varying farmer needs. We will further intensify our efforts to build capabilities in Manufacturing, Digitalization and leverage Collaborations and Alliances”.

Result PDF

Agrochemicals company Rallis India announced Q4FY24 & FY24 results:

Financial Highlights:

  • Revenue: Reported at Rs 2,648 crore in FY24, registering a decrease of 11% compared to the previous year.
  • Profit After Tax (PAT): Rs 148 crore, showing a significant increase from Rs 92 crore in FY23.
  • Dividend:Board recommends a dividend of Rs 2.5 per equity share.
  • Seeds Revenue: Grew by 21%, achieving a break-even profit.
  • Exports Business: Declined by 35% due to geopolitical unrest and ongoing de-stocking.
  • Innovation: Innovation turnover index improved to 16% in FY24.
  • Product Portfolio: Three new products in the Crop nutrition portfolio launched in Q4FY24.

 

 

 

 

Result PDF

Agrochemicals company Rallis India announced Q3FY24 results:

  • The Company recorded revenue of Rs 598 crore for Q3FY24 vs Rs 630 crore in Q3FY23.
  • Profit after tax (after exceptional items) was at Rs 24 crore vs Rs 22 crore in Q3FY23.
  • Continued its focus on refreshing its Domestic crop care portfolio and launched 3 new products in Crop Care & 4 in Seeds
  • CSM: Commercial dispatches done for one active ingredient and one formulation from our new MPP and Formulation facilities respectively.
  • Rallis will commence the construction of integrated R&D facility. Rallis is also planning to further expand capacity of “Pendimethalin"
  • Rallis awarded with Silver award by “ICAI Sustainability Reporting Awards FY23” for BRSR reporting

Announcing the results, Sanjiv Lal, Managing Director & CEO, Rallis India, said, “During the Quarter, our Domestic business maintained its momentum despite challenging external conditions, recording volume growth of 7%. However, challenges continued on the export front due to steep price drop and weak demand on account of continuing inventory overhang at industry level. Our focus on optimizing working capital and margin improvement continues.

We are closely monitoring Global market demand recovery and remain cautious about El Nino conditions. Global agro-chemical demand is still soft and is expected to recover only next financial year.

Meanwhile, the company's long-term strategy remains unchanged and is focused on refreshing the product portfolio, widening of market reach, increasing manufacturing capacities, and digitalization in operations”.

 

Result PDF

Agrochemicals company Rallis India announced Q2FY24 results:

  • The Company recorded revenue of Rs 832 crore for Q2FY24 vs Rs 951 crore over Q2FY23.
  • Profit before tax (before exceptional items) was at Rs 109 crore vs the previous year of Rs 95 crore and the Profit after tax (after exceptional items) was at Rs 82 crore vs Rs 72 crore in Q2FY23.
  • During Q2FY24 Company repaid Rs 75 crore of working capital loan
  • Rallis India continues its focus on refreshing its Domestic crop care portfolio and launched 8 new products in Q2FY24
  • Multi-purpose plant has commenced production of technical “Difencanozole” and is now being prepared for another new CSM product in Q3FY24
  • Cotton hybrids, Diggaz and Aatish, have registered significant growth in North India and Maharashtra & South cotton belt respectively
  • Digitial initiatives are progressing well. Rallis launched “Seedsure” a mobile-enabled tool to digitize its hybrid seed production process

Announcing the results, Sanjiv Lal, Managing Director & CEO, Rallis India, said, “Our revenue has been affected by weak export demand, falling prices, and erratic rainfall in the domestic market. Although our revenue for Q2 FY24 was lower at Rs 832 crore vs Rs 951 crore for Q2FY23, margins have improved through better product mix and cost optimization activities across businesses. Our Crop care revenue was Rs 737 crore vs Rs 923 crore PY, mainly due to lower exports. The seeds business did well through improved sales and strong performance for our Cotton hybrids in particular. The Multi-Purpose Plant at Dahej has been put to use.

Amidst El Nino conditions, we remain cautious about the domestic and international markets. Global Agchem demand continues to remain soft on the back of inventory overhang and lower prices and revival is expected only after Q3FY24. The company's long-term strategy remains unchanged, focused on the expansion of product portfolio, widening of market reach, increasing manufacturing capacities, and digitalisation in operations”.

 

Result PDF

Agrochemicals Company Rallis India announced Q1FY24 results:

  • Revenue of Rs 782 crore for Q1FY24 vs Rs 863 crore over Q1FY23
  • Profit before tax (before exceptional items) was at Rs 85 crore as compared to Q1FY23 of Rs 91 crore
  • Profit after tax (after exceptional items) was Rs 63 crore, as compared to Rs 67 crore in Q1FY23
  • During Q1FY24, the company repaid Rs 25 crore of working capital loan

Announcing the results, Sanjiv Lal, Managing Director & CEO, Rallis India, said, “Crop Care Business has been affected by high market inventories, steep price drops and delayed onset of monsoon. Although our revenues for Q1FY24 were lower at Rs 782 crore vis-a-vis Rs 863 crore of Q1FY23, margins were largely maintained through better product mix and dynamic pricing actions. On the capex front, we are happy to announce that product trials on MPP commenced towards the end of Q1FY24.

We remain cautious about the international market demand recovery during the second half of the year once the inventory situation gradually eases out. Sentiments for the domestic market are positive with the recent uptick in monsoons. We are also closely monitoring the impact of imminent El Nino conditions on the Indian market and farmers.

Notwithstanding the near-term challenges, the company's long-term strategy remains unchanged, focused on increasing manufacturing capacities, product portfolio expansion and widening market reach.”

 

 

 

Result PDF

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Play Store App Store
market app